Envoy Medical Inc./$COCH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.
Ticker
$COCH
Sector
Primary listing
Employees
45
Headquarters
Website
COCH Metrics
BasicAdvanced
$52m
-
-$1.23
2.05
-
Price and volume
Market cap
$52m
Beta
2.05
52-week high
$1.91
52-week low
$0.36
Average daily volume
240k
Financial strength
Current ratio
0.543
Quick ratio
0.328
Long term debt to equity
-6.331
Total debt to equity
-7.81
Interest coverage (TTM)
-13.89%
Profitability
EBITDA (TTM)
-21.778
Gross margin (TTM)
-183.82%
Net profit margin (TTM)
-9,857.26%
Operating margin (TTM)
-9,161.83%
Revenue per employee (TTM)
$10,000
Management effectiveness
Return on assets (TTM)
-137.34%
Return on equity (TTM)
155.22%
Valuation
Price to revenue (TTM)
65.322
Price to book
-1.66
Price to tangible book (TTM)
-1.66
Price to free cash flow (TTM)
-0.779
Free cash flow yield (TTM)
-128.31%
Free cash flow per share (TTM)
-0.868
Growth
Revenue change (TTM)
7.11%
Earnings per share change (TTM)
-17.22%
3-year revenue growth (CAGR)
0.56%
3-year earnings per share growth (CAGR)
-7.81%
COCH News
AllArticlesVideos
Envoy Medical Highlights First Clinical Data Presentations from Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
Newsfile Corp·2 days ago
Envoy Medical Appoints Chas McKhann to Board of Directors
Newsfile Corp·2 weeks ago
Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant
Newsfile Corp·4 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Envoy Medical Inc. stock?
Envoy Medical Inc. (COCH) has a market cap of $52M as of April 30, 2026.
What is the P/E ratio for Envoy Medical Inc. stock?
The price to earnings (P/E) ratio for Envoy Medical Inc. (COCH) stock is 0 as of April 30, 2026.
Does Envoy Medical Inc. stock pay dividends?
No, Envoy Medical Inc. (COCH) stock does not pay dividends to its shareholders as of April 30, 2026.
When is the next Envoy Medical Inc. dividend payment date?
Envoy Medical Inc. (COCH) stock does not pay dividends to its shareholders.
What is the beta indicator for Envoy Medical Inc.?
Envoy Medical Inc. (COCH) has a beta rating of 2.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.